Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REALL CD9 : Molecular Mechanisms Involved in Relapses of Childhood B-acute Lymphoblastic Leukaemia, Role of Non-coding RNA in CD9 Gene Regulation

NCT06649253 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT06649253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06649253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REALL CD9 : Molecular Mechanisms Involved in Relapses of Childhood B-acute Lymphoblastic Leukaemia, Role of Non-coding RNA in CD9 Gene Regulation
Lead sponsor
Rennes University Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 22, 2025
Completion date
April 30, 2035
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoblastic, acute, pediatric